Addus HomeCare (ADUS)
Market Price (11/7/2026): $124.12 | Market Cap: $2.3 BilSector: Health Care | Industry: Health Care Services
Addus HomeCare (ADUS)
Market Price (11/7/2026): $124.12Market Cap: $2.3 BilSector: Health CareIndustry: Health Care Services
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 10% Attractive yieldFCF Yield is 6.3% Low stock price volatilityVol 12M is 27% Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Remote Patient Monitoring, Show more. | Trading close to highsDist 52W High is -2.8% Weak multi-year price returns2Y Excs Rtn is -36%, 3Y Excs Rtn is -28% | Key risksADUS key risks include [1] the potential failure to successfully integrate acquisitions and achieve anticipated synergies from its M&A-focused growth strategy. |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 10% |
| Attractive yieldFCF Yield is 6.3% |
| Low stock price volatilityVol 12M is 27% |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Remote Patient Monitoring, Show more. |
| Trading close to highsDist 52W High is -2.8% |
| Weak multi-year price returns2Y Excs Rtn is -36%, 3Y Excs Rtn is -28% |
| Key risksADUS key risks include [1] the potential failure to successfully integrate acquisitions and achieve anticipated synergies from its M&A-focused growth strategy. |
Qualitative Assessment
AI Analysis | Feedback
Addus HomeCare (ADUS) stock has gained about 10% since 7/31/2026 because of the following key factors:
1. Strong Fiscal Q3 2026 Earnings Exceeding Analyst Expectations.
Addus HomeCare reported adjusted diluted earnings per share (EPS) of $1.83 for fiscal Q3 2026 (ended September 30, 2026), surpassing analyst consensus estimates of $1.79 by 2.1%. Additionally, adjusted EBITDA increased by 13.5% year-over-year to $51.2 million, beating the consensus estimate of $50.34 million by 1.8%. Net income for the quarter also rose significantly by 25.1% to $28.6 million.
2. Strategic Acquisition Driving Future Revenue Growth.
On September 14, 2026, Addus HomeCare announced a definitive agreement to acquire AccentCare, Inc.'s personal care division (excluding New York) for approximately $275.0 million. This acquisition, anticipated to close in fiscal Q1 2027, is projected to add roughly $280 million in annualized revenue, representing an approximate 19% expansion of the company's total revenue base.
Show more
Addus HomeCare (ADUS) stock has gained about 10% since 7/31/2026 because of the following key factors:
1. Strong Fiscal Q3 2026 Earnings Exceeding Analyst Expectations.
Addus HomeCare reported adjusted diluted earnings per share (EPS) of $1.83 for fiscal Q3 2026 (ended September 30, 2026), surpassing analyst consensus estimates of $1.79 by 2.1%. Additionally, adjusted EBITDA increased by 13.5% year-over-year to $51.2 million, beating the consensus estimate of $50.34 million by 1.8%. Net income for the quarter also rose significantly by 25.1% to $28.6 million.
2. Strategic Acquisition Driving Future Revenue Growth.
On September 14, 2026, Addus HomeCare announced a definitive agreement to acquire AccentCare, Inc.'s personal care division (excluding New York) for approximately $275.0 million. This acquisition, anticipated to close in fiscal Q1 2027, is projected to add roughly $280 million in annualized revenue, representing an approximate 19% expansion of the company's total revenue base.
3. Robust Organic Growth Across Key Segments.
The company demonstrated strong organic growth in its core personal care segment, with same-store revenue increasing by 6.9% in fiscal Q3 2026. The home health segment achieved its first positive year-over-year revenue growth in several years, with same-store revenue up 2.5% and admissions increasing by 13.8% compared to fiscal Q3 2025.
4. Enhanced Operational Efficiency and Improved Financial Health.
Addus HomeCare showcased improved operational efficiency, with its adjusted EBITDA margin rising to 13.2% in fiscal Q3 2026, an improvement from 12.5% in the prior-year period. The company also generated $40.9 million in operating cash flow during the quarter and significantly reduced its long-term debt, net of issuance costs, to $21.9 million as of September 30, 2026, down from $121.0 million as of December 31, 2025.
Show less
Stock Movement Drivers
Fundamental Drivers
The 7.6% change in ADUS stock from 7/31/2026 to 11/6/2026 was primarily driven by a 7.4% change in the company's Net Income Margin (%).| (LTM values as of) | 7312026 | 11062026 | Change |
|---|---|---|---|
| Stock Price ($) | 115.48 | 124.31 | 7.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,448 | 1,502 | 3.7% |
| Net Income Margin (%) | 6.9% | 7.4% | 7.4% |
| P/E Multiple | 21.1 | 20.5 | -2.7% |
| Shares Outstanding (Mil) | 18 | 18 | -0.6% |
| Cumulative Contribution | 7.6% |
Market Drivers
7/31/2026 to 11/6/2026| Return | Correlation | |
|---|---|---|
| ADUS | 7.6% | |
| Market (SPY) | -1.6% | -10.6% |
| Sector (XLV) | 13.7% | 45.7% |
Fundamental Drivers
The 28.3% change in ADUS stock from 4/30/2026 to 11/6/2026 was primarily driven by a 11.9% change in the company's P/E Multiple.| (LTM values as of) | 4302026 | 11062026 | Change |
|---|---|---|---|
| Stock Price ($) | 96.89 | 124.31 | 28.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,423 | 1,502 | 5.6% |
| Net Income Margin (%) | 6.7% | 7.4% | 9.7% |
| P/E Multiple | 18.3 | 20.5 | 11.9% |
| Shares Outstanding (Mil) | 18 | 18 | -1.0% |
| Cumulative Contribution | 28.3% |
Market Drivers
4/30/2026 to 11/6/2026| Return | Correlation | |
|---|---|---|
| ADUS | 28.3% | |
| Market (SPY) | 2.6% | -9.7% |
| Sector (XLV) | 27.1% | 37.8% |
Fundamental Drivers
The 6.3% change in ADUS stock from 10/31/2025 to 11/6/2026 was primarily driven by a 17.9% change in the company's Total Revenues ($ Mil).| (LTM values as of) | 10312025 | 11062026 | Change |
|---|---|---|---|
| Stock Price ($) | 116.89 | 124.31 | 6.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,274 | 1,502 | 17.9% |
| Net Income Margin (%) | 6.5% | 7.4% | 13.5% |
| P/E Multiple | 25.4 | 20.5 | -19.4% |
| Shares Outstanding (Mil) | 18 | 18 | -1.4% |
| Cumulative Contribution | 6.3% |
Market Drivers
10/31/2025 to 11/6/2026| Return | Correlation | |
|---|---|---|
| ADUS | 6.3% | |
| Market (SPY) | 8.7% | 6.9% |
| Sector (XLV) | 29.8% | 32.0% |
Fundamental Drivers
The 57.6% change in ADUS stock from 10/31/2023 to 11/6/2026 was primarily driven by a 45.9% change in the company's Total Revenues ($ Mil).| (LTM values as of) | 10312023 | 11062026 | Change |
|---|---|---|---|
| Stock Price ($) | 78.90 | 124.31 | 57.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,029 | 1,502 | 45.9% |
| Net Income Margin (%) | 5.6% | 7.4% | 31.9% |
| P/E Multiple | 21.9 | 20.5 | -6.4% |
| Shares Outstanding (Mil) | 16 | 18 | -12.5% |
| Cumulative Contribution | 57.6% |
Market Drivers
10/31/2023 to 11/6/2026| Return | Correlation | |
|---|---|---|
| ADUS | 57.6% | |
| Market (SPY) | 81.9% | 24.6% |
| Sector (XLV) | 55.4% | 29.2% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| ADUS Return | -20% | 6% | -7% | 35% | -14% | 16% | 6% |
| Peers Return | 15% | -18% | 72% | 21% | 50% | 34% | 292% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 12% | 105% |
Monthly Win Rates [3] | |||||||
| ADUS Win Rate | 33% | 50% | 50% | 67% | 58% | 45% | |
| Peers Win Rate | 50% | 42% | 62% | 58% | 55% | 55% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 45% | |
Max Drawdowns [4] | |||||||
| ADUS Max Drawdown | -43% | -25% | -31% | -12% | -34% | -25% | |
| Peers Max Drawdown | -25% | -50% | -23% | -25% | -30% | -32% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: ENSG, AVAH, CHE, BTSG, OPCH. See ADUS Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 11/6/2026 (YTD)
How Low Can It Go
| Event | ADUS | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -20.7% | -18.8% |
| % Gain to Breakeven | 26.0% | 23.1% |
| Time to Breakeven | 67 days | 79 days |
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -13.6% | -9.5% |
| % Gain to Breakeven | 15.7% | 10.5% |
| Time to Breakeven | 34 days | 24 days |
| 2023 SVB Regional Banking Crisis | ||
| % Loss | -24.4% | -6.7% |
| % Gain to Breakeven | 32.2% | 7.1% |
| Time to Breakeven | 370 days | 31 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -24.8% | -24.5% |
| % Gain to Breakeven | 32.9% | 32.4% |
| Time to Breakeven | 148 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -51.4% | -33.7% |
| % Gain to Breakeven | 105.9% | 50.9% |
| Time to Breakeven | 139 days | 140 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -42.6% | -12.2% |
| % Gain to Breakeven | 74.3% | 13.9% |
| Time to Breakeven | 236 days | 62 days |
In The Past
Addus HomeCare's stock fell -20.7% during the 2025 US Tariff Shock. Such a loss loss requires a 26.0% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | ADUS | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -20.7% | -18.8% |
| % Gain to Breakeven | 26.0% | 23.1% |
| Time to Breakeven | 67 days | 79 days |
| 2023 SVB Regional Banking Crisis | ||
| % Loss | -24.4% | -6.7% |
| % Gain to Breakeven | 32.2% | 7.1% |
| Time to Breakeven | 370 days | 31 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -24.8% | -24.5% |
| % Gain to Breakeven | 32.9% | 32.4% |
| Time to Breakeven | 148 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -51.4% | -33.7% |
| % Gain to Breakeven | 105.9% | 50.9% |
| Time to Breakeven | 139 days | 140 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -42.6% | -12.2% |
| % Gain to Breakeven | 74.3% | 13.9% |
| Time to Breakeven | 236 days | 62 days |
| 2014-2016 Oil Price Collapse | ||
| % Loss | -21.0% | -6.8% |
| % Gain to Breakeven | 26.6% | 7.3% |
| Time to Breakeven | 50 days | 15 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -44.8% | -17.9% |
| % Gain to Breakeven | 81.1% | 21.8% |
| Time to Breakeven | 399 days | 123 days |
In The Past
Addus HomeCare's stock fell -20.7% during the 2025 US Tariff Shock. Such a loss loss requires a 26.0% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Addus HomeCare (ADUS)
Addus HomeCare Corporation (ADUS) is a leading provider of comprehensive in-home healthcare services across the United States. The company's core mission is to support elderly, chronically ill, or disabled individuals, as well as those who are terminally ill, by delivering essential care in their homes. This approach helps these individuals maintain independence, improve their quality of life, and often prevents the need for hospitalization or institutionalization. Addus operates through three primary segments, each addressing distinct needs within the homecare spectrum.
The company's main services include Personal Care, Hospice, and Home Health. The Personal Care segment offers non-medical assistance with daily living activities, such as bathing, grooming, meal preparation, medication reminders, housekeeping, and transportation. The Hospice segment focuses on providing palliative nursing care, social work, spiritual counseling, and bereavement support for terminally ill individuals and their families. Lastly, the Home Health segment delivers skilled nursing care along with physical, occupational, and speech therapy services for individuals recovering from illness or hospitalization.
Addus HomeCare serves a diverse client base, including federal, state, and local governmental agencies, managed care organizations, and commercial insurers, as well as private individuals who pay for services directly. The company's extensive network spans 22 states, where it operates through 206 offices, allowing it to provide vital care to a broad population across various regions of the country.
AI Analysis | Feedback
Think of Addus HomeCare as **Home Instead Senior Care**, but also offering professional medical home health and hospice services.
Imagine it like **Teladoc or MDLive**, but for a broad range of in-person home care services, including personal assistance, skilled nursing, and hospice.
Consider it like **Uber or Lyft**, but for dispatching trained caregivers and nurses directly to people's homes to provide a spectrum of personal, medical, and hospice care services.
AI Analysis | Feedback
- Personal Care Services: Provides non-medical assistance with daily living activities such as bathing, grooming, feeding, medication reminders, meal preparation, housekeeping, and transportation.
- Hospice Services: Offers palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling for terminally ill individuals and their families.
- Home Health Services: Delivers skilled nursing and physical, occupational, and speech therapy for individuals requiring assistance during an illness or after hospitalization.
AI Analysis | Feedback
Addus HomeCare (ADUS) primarily serves individuals who require assistance with daily living, palliative care, or skilled nursing and therapy during illness or post-hospitalization. Based on the company's description of who it provides services to, its major customers fall into the following categories:
- Elderly persons
- Chronically ill persons
- Disabled persons
AI Analysis | Feedback
AI Analysis | Feedback
Dirk Allison, Chairman and Chief Executive Officer
Dirk Allison joined Addus HomeCare as President and Chief Executive Officer in January 2016 and was named Chairman of the Board and Chief Executive Officer in March 2021, having served on its board of directors since 2010. He brings over 29 years of leadership experience in various healthcare segments. His prior roles include President and CEO of Correctional Healthcare Companies, Inc. from 2013 to 2014, and President and CEO of CCS Medical, Inc. from 2011 to 2013. Earlier, he was Senior Vice President, Chief Financial Officer, and Treasurer of Odyssey Healthcare, Inc., which was acquired by Gentiva Health Services, Inc. in 2010. He also held executive finance positions at Omniflight, Inc., Ardent Health Services LLC, and Renal Care Group, Inc., and served as President and CEO of several publicly and privately held companies between 1987 and 1999. His experience includes leadership at Oceans Healthcare, a private equity-backed behavioral healthcare provider, indicating a pattern of managing companies with private equity backing.
Brian Poff, Executive Vice President and Chief Financial Officer
Brian Poff became Executive Vice President and Chief Financial Officer in May 2016, bringing over 16 years of accounting and finance experience primarily in public and private healthcare organizations. Prior to Addus, he was Chief Financial Officer and Treasurer of Oceans Healthcare, a private equity-backed behavioral health care provider. He also served as Senior Vice President of Finance and Chief Accounting Officer for CCS Medical, Corporate Controller for AccentCare, Inc., and Division Chief Financial Officer for Hospice Services at Gentiva Health Services. Poff was Assistant Controller for Odyssey HealthCare, Inc., which was acquired by Gentiva Health Services, and Controller for Horizon Health Corporation until its acquisition by Psychiatric Solutions, Inc. His background includes managing companies with private equity backing.
Heather Dixon, President and Chief Operating Officer
Heather Dixon was appointed President and Chief Operating Officer in September 2025. A Certified Public Accountant, she previously served as Chief Financial Officer of Acadia Healthcare and held positions as Chief Financial Officer and interim Chief Operating Officer at Everside Health. Her career also includes senior leadership roles as Senior Vice President, Global Controller and Chief Accounting Officer for Walgreens Boots Alliance, Inc. and Vice President, Controller and Chief Accounting Officer for Aetna. She began her professional career at PricewaterhouseCoopers and served as an independent board member of Signify Health until its acquisition by CVS Health in March 2023.
Darby Anderson, Executive Vice President and Chief Government Relations Officer
Darby Anderson joined Addus HomeCare in 1996 as Midwest Regional Manager, progressing to Regional Vice President of Midwest/East in 2000, and serving as Senior Vice President until December 2014. He is currently Executive Vice President and Chief Government Relations Officer. Anderson has also held board and advisory committee positions, including with the Older Adult Services Advisory Committee and the Community Care Program Advisory Committee in Illinois.
Sean Gaffney, Executive Vice President and Chief Legal Officer
Sean Gaffney became Executive Vice President and Chief Legal Officer of Addus HomeCare in April 2019. Before joining Addus, he served as General Counsel at Encompass Health – Home Health & Hospice. Prior to that, he was Executive Vice President of Corporate Development, General Counsel, and Secretary of BroadJump, LLC, a software start-up.
AI Analysis | Feedback
The key risks to Addus HomeCare's (ADUS) business are primarily rooted in the evolving healthcare regulatory landscape, persistent workforce challenges, and intense market competition.
- Regulatory Changes and Reimbursement Pressures: Addus HomeCare relies significantly on government-funded programs like Medicaid and Medicare for a substantial portion of its revenue. Consequently, the company is highly susceptible to changes in government policies, funding levels, and reimbursement models. A prominent example is the Medicaid Access Rule, which mandates that 80% of funds be spent on compensation, posing a risk to the company's margins if reimbursement rates do not increase to offset these costs. Shifts in policy and potential cuts to government healthcare programs could compress Addus's margins and affect its revenue streams.
- Workforce Shortages and Wage Inflation: The home healthcare industry, in which Addus operates, faces a significant and ongoing challenge with caregiver recruitment and retention. This shortage leads to increased wage inflation and high turnover rates, directly impacting Addus's operating costs and gross margins, as it is a labor-intensive business. The difficulty in finding and keeping qualified staff can also limit the company's capacity to meet growing demand and expand services.
- Increased Competition and Managed Care Organization Dynamics: The home care services market is highly competitive, with many providers vying for market share. Addus HomeCare's increasing reliance on Managed Care Organizations (MCOs) as payor clients also presents a risk. This shift can potentially reduce Addus's bargaining power, leading to lower negotiated rates and increased pressure on profitability and growth.
AI Analysis | Feedback
AI Analysis | Feedback
- Personal Care: The U.S. personal care services market was valued at approximately USD 455.13 billion in 2025. This market is driven by factors such as the increasing aging population, which requires services to maintain independence and support daily living activities.
- Hospice: The U.S. hospice market was estimated at USD 29.92 billion in 2024. This market is projected to grow to USD 39.09 billion by 2030, driven by the rising prevalence of chronic diseases among the geriatric population and the increasing need for quality end-of-life care at home.
- Home Health: The U.S. home healthcare services market size was valued at USD 100.95 billion in 2024. This market is projected to grow to USD 176.30 billion by 2032, with nursing care dominating due to the increasing demand for skilled nursing care at home, particularly among the geriatric population.
AI Analysis | Feedback
Addus HomeCare Corporation (ADUS) is expected to experience future revenue growth over the next two to three years driven by several key factors:
- Organic Growth in Personal Care and Hospice Segments: Addus anticipates continued organic expansion within its Personal Care and Hospice segments. The Personal Care segment is expected to benefit from increased service volumes and a rise in authorized hours served, with the impact of Medicaid redeterminations in states like Illinois nearing its conclusion. The Hospice segment is also poised for growth through higher admissions, an increased average daily census, and improved revenue per patient day.
- State-Mandated Rate Increases: Favorable reimbursement rate increases, particularly in significant markets such as Illinois and Texas, are identified as a direct contributor to revenue growth. These rate adjustments improve the revenue generated per service provided.
- Strategic Acquisitions: Addus HomeCare has a proven track record of growth through strategic acquisitions, and management has indicated plans to continue pursuing selective acquisitions in 2026. The company's strong financial position is expected to support these bolt-on deals, contributing to both market density and expansion into new areas.
- Growing Demand for Home-Based Care: The fundamental demographic trend of an aging population, coupled with a societal preference for in-home care due to its value and cost-efficiency compared to institutional settings, is a sustained driver of demand for Addus's services across its segments.
- Improved Labor Market Conditions: A softening labor market, especially in key operational states such as Illinois, is expected to alleviate caregiver shortages. This increased availability of workers can enable Addus to serve a greater number of authorized hours and clients, thereby driving volume-based revenue growth.
AI Analysis | Feedback
Share Repurchases
- Addus HomeCare completed a $250.0 million stock repurchase in 2024.
Share Issuance
- In June 2024, Addus HomeCare raised $175.6 million through a public offering of 1,725,000 shares of common stock at $108.00 per share.
- The net proceeds from this offering were intended for the repayment of outstanding indebtedness under its credit facility and for general corporate purposes, including future acquisitions.
Outbound Investments
- In December 2024, Addus HomeCare completed the acquisition of the personal care operations of Gentiva for approximately $350 million, expanding its market coverage in seven states and entering Texas and Missouri as new markets.
- During 2023, Addus HomeCare acquired Tennessee Quality Care for $106 million and also acquired Coastal Nursecare of Florida, Inc.
- In 2022, the company purchased Illinois-based hospice provider JourneyCare Inc. for $85 million and acquired Chicago-based Apple Home Health Ltd.
Capital Expenditures
- Addus HomeCare continues to invest in technologies that support its operations and enhance the work of its caregivers.
- The company's capital expenditures for environmental matters were not material during the year ended December 31, 2024.
Peer Outperformance in Health Care Services
| Ticker | Name | Rev Growth 3Y Avg | P/E | 1Y | 3Y | 5Y | 5Y Gap |
|---|---|---|---|---|---|---|---|
| ADUS | Addus HomeCare | 13.5% | 20.5x | 8.9% | 48.4% | 21.8% | — |
| RDNT | RadNet | 14.1% | -280.0x | -3.7% | 158.2% | 119.7% | +98pp |
| CI | Cigna | 14.9% | 12.9x | 17.1% | 5.5% | 50.5% | +29pp |
| Industry | Names | 1Y med | 3Y med | 5Y med | Top 3 by 5Y |
|---|---|---|---|---|---|
| Health Care Distributors | 6 | 8.1% | 55.6% | 91.6% | CAH 507% · MCK 390% · COR 176% |
| Health Care Services ← | 20 | 33.3% | 22.4% | 7.1% | HIMS 212% · RDNT 120% · DGX 100% |
| Health Care Facilities | 25 | 13.7% | 21.0% | 1.0% | THC 276% · NHC 212% · EHC 179% |
| Managed Health Care | 8 | 58.5% | -2.5% | -2.4% | OSCR 80% · HQY 52% · ELV 8% |
| Health Care Equipment | 50 | 11.3% | 12.9% | -18.2% | UFPT 361% · GKOS 294% · TMDX 180% |
| Pharmaceuticals | 61 | -9.5% | 10.3% | -37.3% | LQDA 975% · XERS 679% · KNSA 537% |
| Health Care Supplies | 11 | 29.2% | 17.3% | -41.2% | LNTH 248% · HAE 61% · MMSI 26% |
| Life Sciences Tools & Services | 108 | -8.2% | -13.1% | -74.5% | AXGN 264% · MEDP 189% · NTRA 168% |
| Biotechnology | 364 | -24.2% | -34.6% | -81.5% | ELVN 1194% · TRVI 1125% · DNTH 995% |
| Health Care Technology | 21 | -23.7% | -52.4% | -82.9% | VEEV -5% · DOCS -52% |
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| Addus HomeCare Earnings Notes | 12/31/2026 | |
| How Low Can Addus HomeCare Stock Really Go? | 10/17/2025 | |
| ADUS Dip Buy Analysis | 07/10/2025 | |
| Addus HomeCare (ADUS) Operating Cash Flow Comparison | 02/17/2025 | |
| Addus HomeCare (ADUS) Net Income Comparison | 02/15/2025 | |
| Addus HomeCare (ADUS) Operating Income Comparison | 02/14/2025 | |
| Addus HomeCare (ADUS) Revenue Comparison | 02/13/2025 | |
| ARTICLES | ||
| 78 Small Cap Stocks Hit 52-Week Highs On Wednesday | 11/05/2026 | |
| 43 Small Cap Stocks Hit 52-Week Highs On Thursday | 10/30/2026 | |
| Better Bet Than RadNet Stock: Pay Less To Get More From ADUS | 08/26/2025 | |
| Better Bet Than Premier Stock: Pay Less To Get More From ADUS, CHE | 08/16/2025 |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 95.64 |
| Mkt Cap | 5.8 |
| Rev LTM | 4,168 |
| Op Inc LTM | 356 |
| FCF LTM | 220 |
| FCF 3Y Avg | 191 |
| CFO LTM | 343 |
| CFO 3Y Avg | 328 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 14.5% |
| Rev Chg 3Y Avg | 13.0% |
| Rev Chg Q | 12.1% |
| QoQ Delta Rev Chg LTM | 2.9% |
| Op Inc Chg LTM | 26.2% |
| Op Inc Chg 3Y Avg | 21.6% |
| Op Mgn LTM | 9.7% |
| Op Mgn 3Y Avg | 8.5% |
| QoQ Delta Op Mgn LTM | 0.3% |
| CFO/Rev LTM | 8.3% |
| CFO/Rev 3Y Avg | 7.9% |
| FCF/Rev LTM | 5.5% |
| FCF/Rev 3Y Avg | 4.2% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 5.8 |
| P/S | 1.3 |
| P/Op Inc | 16.5 |
| P/EBIT | 16.1 |
| P/E | 23.2 |
| P/CFO | 16.1 |
| Total Yield | 4.6% |
| Dividend Yield | 0.0% |
| FCF Yield 3Y Avg | 4.1% |
| D/E | 0.2 |
| Net D/E | 0.2 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 6.1% |
| 3M Rtn | 5.6% |
| 6M Rtn | 24.7% |
| 12M Rtn | 20.2% |
| 3Y Rtn | 62.5% |
| 1M Excs Rtn | 6.7% |
| 3M Excs Rtn | 7.5% |
| 6M Excs Rtn | 20.8% |
| 12M Excs Rtn | 5.8% |
| 3Y Excs Rtn | -10.3% |
Comparison Analyses
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Personal Care | 1,089 | 857 | 795 | 707 | 686 |
| Hospice | 263 | 228 | 207 | 202 | 152 |
| Home Health | 71 | 70 | 57 | 43 | 26 |
| Total | 1,423 | 1,155 | 1,059 | 951 | 864 |
| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Personal Care | 207 | 174 | 158 | 125 | 122 |
| Hospice | 67 | 52 | 45 | 51 | 42 |
| Home Health | 12 | 8 | 7 | 3 | 3 |
| Depreciation and amortization | -16 | -14 | -14 | -14 | -14 |
| Other general and administrative expenses | -132 | -118 | -104 | -96 | -88 |
| Total | 139 | 103 | 91 | 69 | 66 |
| $ Mil | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|
| Home & Community | 118 | 122 | 118 | 91 |
| Corporate | 23 | 16 | 20 | |
| Home Health | 14 | 29 | 27 | 24 |
| General corporate expenses & corporate depreciation | 16 | |||
| Total | 155 | 167 | 161 | 136 |
Price Behavior
| Market Price | $124.31 | |
| Market Cap ($ Bil) | 2.3 | |
| First Trading Date | 10/28/2009 | |
| Distance from 52W High | -2.8% | |
| 50 Days | 200 Days | |
| DMA Price | $117.60 | $106.78 |
| DMA Trend | indeterminate | up |
| Distance from DMA | 5.7% | 16.4% |
| 3M | 1YR | |
| Volatility | 20.5% | 27.3% |
| Downside Capture | -8.39 | 16.97 |
| Upside Capture | 32.57 | 22.13 |
| Correlation (S&P 500) | -16.4% | 3.7% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | -0.62 | -0.43 | -0.48 | -0.30 | 0.13 | 0.47 |
| Up Beta | -1.92 | -1.78 | -1.41 | -0.44 | -0.15 | 0.46 |
| Down Beta | -0.96 | -1.29 | -1.32 | -0.52 | 0.10 | 0.14 |
| Up Capture | 72% | 34% | 17% | 8% | 18% | 36% |
| Bmk +ve Days | 12 | 18 | 28 | 62 | 130 | 427 |
| Stock +ve Days | 14 | 22 | 33 | 70 | 126 | 382 |
| Down Capture | -134% | -43% | -34% | -70% | 27% | 84% |
| Bmk -ve Days | 10 | 25 | 36 | 64 | 121 | 325 |
| Stock -ve Days | 8 | 21 | 31 | 56 | 123 | 365 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with ADUS | |
|---|---|---|---|---|
| ADUS | 3.7% | 27.3% | 0.11 | - |
| Sector ETF (XLV) | 28.6% | 16.9% | 1.31 | 33.8% |
| Equity (SPY) | 9.5% | 13.6% | 0.40 | 4.7% |
| Gold (GLD) | 1.6% | 28.7% | 0.05 | 3.1% |
| Commodities (DBC) | 38.4% | 21.2% | 1.42 | -10.7% |
| Real Estate (VNQ) | 11.3% | 14.2% | 0.51 | 21.9% |
| Bitcoin (BTCUSD) | -26.9% | 43.6% | -0.60 | 3.0% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with ADUS | |
|---|---|---|---|---|
| ADUS | 5.9% | 33.8% | 0.23 | - |
| Sector ETF (XLV) | 8.3% | 15.4% | 0.35 | 33.0% |
| Equity (SPY) | 11.3% | 17.3% | 0.48 | 31.4% |
| Gold (GLD) | 17.5% | 19.1% | 0.74 | 3.7% |
| Commodities (DBC) | 8.1% | 19.6% | 0.30 | -0.0% |
| Real Estate (VNQ) | 1.3% | 18.9% | -0.04 | 28.7% |
| Bitcoin (BTCUSD) | 4.1% | 51.6% | 0.26 | 17.2% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with ADUS | |
|---|---|---|---|---|
| ADUS | 17.3% | 38.8% | 0.53 | - |
| Sector ETF (XLV) | 12.2% | 16.8% | 0.59 | 35.1% |
| Equity (SPY) | 15.0% | 18.0% | 0.70 | 33.7% |
| Gold (GLD) | 11.9% | 16.5% | 0.59 | 4.8% |
| Commodities (DBC) | 7.5% | 18.1% | 0.33 | 7.7% |
| Real Estate (VNQ) | 5.9% | 20.7% | 0.24 | 27.5% |
| Bitcoin (BTCUSD) | 60.1% | 66.3% | 1.00 | 9.7% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Updated 11/6/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 11/3/2026 | 1.1% | ||
| 8/3/2026 | -2.7% | 2.2% | -1.9% |
| 5/4/2026 | -1.7% | -2.3% | -11.6% |
| 2/23/2026 | -10.6% | -10.5% | -15.6% |
| 11/3/2025 | -5.7% | -5.2% | -4.1% |
| 8/4/2025 | 9.0% | 4.7% | 5.7% |
| 5/5/2025 | 4.1% | 5.9% | 7.3% |
| 2/24/2025 | -10.4% | -12.7% | -12.7% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 13 | 13 | 11 |
| # Negative | 12 | 11 | 13 |
| Median Positive | 5.8% | 6.6% | 7.3% |
| Median Negative | -4.4% | -5.8% | -5.0% |
| Max Positive | 12.9% | 13.0% | 17.4% |
| Max Negative | -10.6% | -17.9% | -15.6% |
| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 11/3/2026 | 1.1% | ||
| 8/3/2026 | -2.7% | 2.2% | -1.9% |
| 5/4/2026 | -1.7% | -2.3% | -11.6% |
| 2/23/2026 | -10.6% | -10.5% | -15.6% |
| 11/3/2025 | -5.7% | -5.2% | -4.1% |
| 8/4/2025 | 9.0% | 4.7% | 5.7% |
| 5/5/2025 | 4.1% | 5.9% | 7.3% |
| 2/24/2025 | -10.4% | -12.7% | -12.7% |
| 11/4/2024 | -3.7% | -0.8% | -4.2% |
| 8/5/2024 | 5.8% | 6.6% | 10.9% |
| 5/6/2024 | 6.8% | 13.0% | 17.2% |
| 2/26/2024 | 5.5% | 9.6% | 17.4% |
| 10/30/2023 | -5.2% | 2.0% | 5.4% |
| 7/31/2023 | 1.5% | 2.9% | -2.5% |
| 5/1/2023 | -2.6% | -5.8% | 1.5% |
| 2/27/2023 | 2.6% | -2.2% | -1.5% |
| 10/31/2022 | 6.0% | 7.2% | 7.7% |
| 8/1/2022 | 0.5% | -1.9% | -7.1% |
| 5/3/2022 | -2.3% | -7.0% | -4.2% |
| 2/24/2022 | 12.9% | 7.0% | 8.5% |
| 11/1/2021 | -3.1% | 8.0% | -11.2% |
| 8/3/2021 | 11.3% | 9.3% | 5.7% |
| 5/3/2021 | -5.9% | -8.3% | -9.3% |
| 2/25/2021 | -5.0% | -17.9% | -5.0% |
| 11/3/2020 | 8.0% | 0.4% | 0.9% |
| SUMMARY STATS | |||
| # Positive | 13 | 13 | 11 |
| # Negative | 12 | 11 | 13 |
| Median Positive | 5.8% | 6.6% | 7.3% |
| Median Negative | -4.4% | -5.8% | -5.0% |
| Max Positive | 12.9% | 13.0% | 17.4% |
| Max Negative | -10.6% | -17.9% | -15.6% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 09/30/2026 | 11/04/2026 | 10-Q |
| 06/30/2026 | 08/04/2026 | 10-Q |
| 03/31/2026 | 05/05/2026 | 10-Q |
| 12/31/2025 | 02/24/2026 | 10-K |
| 09/30/2025 | 11/04/2025 | 10-Q |
| 06/30/2025 | 08/05/2025 | 10-Q |
| 03/31/2025 | 05/06/2025 | 10-Q |
| 12/31/2024 | 02/25/2025 | 10-K |
| 09/30/2024 | 11/05/2024 | 10-Q |
| 06/30/2024 | 08/06/2024 | 10-Q |
| 03/31/2024 | 05/07/2024 | 10-Q |
| 12/31/2023 | 02/27/2024 | 10-K |
| 09/30/2023 | 10/31/2023 | 10-Q |
| 06/30/2023 | 08/01/2023 | 10-Q |
| 03/31/2023 | 05/02/2023 | 10-Q |
| 12/31/2022 | 02/28/2023 | 10-K |
| Report Date | Filing Date | Filing |
|---|---|---|
| 09/30/2026 | 11/04/2026 | 10-Q |
| 06/30/2026 | 08/04/2026 | 10-Q |
| 03/31/2026 | 05/05/2026 | 10-Q |
| 12/31/2025 | 02/24/2026 | 10-K |
| 09/30/2025 | 11/04/2025 | 10-Q |
| 06/30/2025 | 08/05/2025 | 10-Q |
| 03/31/2025 | 05/06/2025 | 10-Q |
| 12/31/2024 | 02/25/2025 | 10-K |
| 09/30/2024 | 11/05/2024 | 10-Q |
| 06/30/2024 | 08/06/2024 | 10-Q |
| 03/31/2024 | 05/07/2024 | 10-Q |
| 12/31/2023 | 02/27/2024 | 10-K |
| 09/30/2023 | 10/31/2023 | 10-Q |
| 06/30/2023 | 08/01/2023 | 10-Q |
| 03/31/2023 | 05/02/2023 | 10-Q |
| 12/31/2022 | 02/28/2023 | 10-K |
| 09/30/2022 | 11/01/2022 | 10-Q |
| 06/30/2022 | 08/02/2022 | 10-Q |
| 03/31/2022 | 05/03/2022 | 10-Q |
| 12/31/2021 | 02/25/2022 | 10-K |
| 09/30/2021 | 11/02/2021 | 10-Q |
| 06/30/2021 | 08/04/2021 | 10-Q |
| 03/31/2021 | 05/07/2021 | 10-Q |
| 12/31/2020 | 03/01/2021 | 10-K |
| 09/30/2020 | 11/06/2020 | 10-Q |
| 06/30/2020 | 08/10/2020 | 10-Q |
| 03/31/2020 | 08/10/2020 | 10-Q |
| 12/31/2019 | 08/10/2020 | 10-K |
Insider Activity
Updated 6/23/2026| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Dixon, Heather Brianne | President and Chief Operating | Direct | Sell | 6232026 | 93.77 | 288 | 27,006 | 4,160,669 | Form |
| 2 | Lopez, Esteban | Direct | Sell | 5222026 | 93.00 | 250 | 23,250 | 297,600 | Form | |
| 3 | Lopez, Esteban | Direct | Sell | 5212026 | 93.00 | 250 | 23,250 | 320,850 | Form | |
| 4 | Blessing, Cliff Donald | EVP, Chief Development Officer | Direct | Sell | 4222026 | 93.61 | 178 | 16,663 | 1,140,451 | Form |
| 5 | Raines, Monica | EVP, CCO and Quality Officer | Direct | Sell | 3032026 | 102.15 | 224 | 22,882 | 1,386,891 | Form |
| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Dixon, Heather Brianne | President and Chief Operating | Direct | Sell | 6232026 | 93.77 | 288 | 27,006 | 4,160,669 | Form |
| 2 | Lopez, Esteban | Direct | Sell | 5222026 | 93.00 | 250 | 23,250 | 297,600 | Form | |
| 3 | Lopez, Esteban | Direct | Sell | 5212026 | 93.00 | 250 | 23,250 | 320,850 | Form | |
| 4 | Blessing, Cliff Donald | EVP, Chief Development Officer | Direct | Sell | 4222026 | 93.61 | 178 | 16,663 | 1,140,451 | Form |
| 5 | Raines, Monica | EVP, CCO and Quality Officer | Direct | Sell | 3032026 | 102.15 | 224 | 22,882 | 1,386,891 | Form |
| 6 | Raines, Monica | EVP, CCO and Quality Officer | Direct | Sell | 2262026 | 105.36 | 219 | 23,074 | 1,454,073 | Form |
| 7 | Stevenson, Roberton James | EVP, Chief HR Officer | Direct | Sell | 2262026 | 105.36 | 284 | 29,922 | 1,478,201 | Form |
| 8 | Blessing, Cliff Donald | EVP, Chief Development Officer | Direct | Sell | 2262026 | 105.36 | 177 | 18,649 | 1,302,355 | Form |
| 9 | Wattenbarger, Michael D | EVP, Chief Information Officer | Direct | Sell | 2262026 | 105.36 | 300 | 31,608 | 995,020 | Form |
| 10 | Tucker, David W | EVP, Chief Strategy Officer | Direct | Sell | 2262026 | 105.36 | 379 | 39,931 | 1,098,167 | Form |
| 11 | Anderson, Darby | EVP, Chief Govt Rel Officer | Direct | Sell | 2262026 | 105.36 | 396 | 41,723 | 4,872,479 | Form |
| 12 | Gaffney, Sean | EVP, Chief Legal Officer | Direct | Sell | 2262026 | 105.36 | 442 | 46,569 | 2,115,629 | Form |
| 13 | Poff, Brian | EVP, Chief Financial Officer | Direct | Sell | 2262026 | 105.36 | 820 | 86,395 | 6,710,589 | Form |
| 14 | Allison, R Dirk | Chairman and CEO | Direct | Sell | 2262026 | 105.36 | 2,364 | 249,071 | 19,296,684 | Form |
| 15 | Raines, Monica | EVP, CCO and Quality Officer | Direct | Sell | 2262026 | 106.99 | 437 | 46,755 | 1,500,000 | Form |
| 16 | Stevenson, Roberton James | EVP, Chief HR Officer | Direct | Sell | 2262026 | 107.35 | 567 | 60,867 | 1,536,608 | Form |
| 17 | Blessing, Cliff Donald | EVP, Chief Development Officer | Direct | Sell | 2262026 | 107.14 | 350 | 37,499 | 1,343,321 | Form |
| 18 | Wattenbarger, Michael D | EVP, Chief Information Officer | Direct | Sell | 2262026 | 107.35 | 592 | 63,551 | 1,046,018 | Form |
| 19 | Tucker, David W | EVP, Chief Strategy Officer | Direct | Sell | 2262026 | 107.35 | 704 | 75,574 | 1,159,595 | Form |
| 20 | Anderson, Darby | EVP, Chief Govt Rel Officer | Direct | Sell | 2262026 | 106.98 | 733 | 78,416 | 4,989,761 | Form |
| 21 | Gaffney, Sean | EVP, Chief Legal Officer | Direct | Sell | 2262026 | 106.98 | 817 | 87,403 | 2,195,444 | Form |
| 22 | Poff, Brian | EVP, Chief Financial Officer | Direct | Sell | 2262026 | 106.98 | 2,041 | 218,346 | 6,901,494 | Form |
| 23 | Allison, R Dirk | Chairman and CEO | Direct | Sell | 2262026 | 106.98 | 4,988 | 533,616 | 19,846,288 | Form |
| 24 | Raines, Monica | EVP, CCO and Quality Officer | Direct | Sell | 2242026 | 114.91 | 446 | 51,250 | 1,661,254 | Form |
| 25 | Stevenson, Roberton James | EVP, Chief HR Officer | Direct | Sell | 2242026 | 114.91 | 561 | 64,465 | 1,709,976 | Form |
| 26 | Blessing, Cliff Donald | EVP, Chief Development Officer | Direct | Sell | 2242026 | 114.91 | 371 | 42,632 | 1,480,960 | Form |
| 27 | Wattenbarger, Michael D | EVP, Chief Information Officer | Direct | Sell | 2242026 | 114.91 | 577 | 66,303 | 1,187,710 | Form |
| 28 | Tucker, David W | EVP, Chief Strategy Officer | Direct | Sell | 2242026 | 114.91 | 658 | 75,611 | 1,322,154 | Form |
| 29 | Anderson, Darby | EVP, Chief Govt Rel Officer | Direct | Sell | 2242026 | 114.91 | 666 | 76,530 | 5,443,861 | Form |
| 30 | Gaffney, Sean | EVP, Chief Legal Officer | Direct | Sell | 2242026 | 114.91 | 737 | 84,689 | 2,452,064 | Form |
| 31 | Poff, Brian | EVP, Chief Financial Officer | Direct | Sell | 2242026 | 114.91 | 1,858 | 213,503 | 7,647,605 | Form |
| 32 | Allison, R Dirk | Chairman and CEO | Direct | Sell | 2242026 | 114.91 | 4,535 | 521,117 | 21,890,585 | Form |
| 33 | Lopez, Esteban | Direct | Sell | 12162025 | 115.18 | 150 | 17,278 | 426,178 | Form | |
| 34 | Lopez, Esteban | Direct | Sell | 12082025 | 112.78 | 166 | 18,721 | 434,203 | Form | |
| 35 | Anderson, Darby | EVP, Chief Govt Rel Officer | Direct | Sell | 11202025 | 109.00 | 20,000 | 2,180,000 | 4,811,696 | Form |
| 36 | Bickham, W Bradley | President and COO | Direct | Sell | 9032025 | 115.75 | 4,000 | 463,000 | 4,352,779 | Form |
| 37 | Allison, R Dirk | Chairman and CEO | Direct | Sell | 9032025 | 115.83 | 25,000 | 2,895,750 | 19,281,176 | Form |
| 38 | Poff, Brian | EVP, Chief Financial Officer | Direct | Sell | 8262025 | 116.82 | 7,739 | 904,088 | 6,656,533 | Form |
| 39 | Allison, R Dirk | Chairman and CEO | Direct | Sell | 8212025 | 114.95 | 25,000 | 2,873,851 | 19,135,363 | Form |
| 40 | Hill-Milbourne, Veronica | Direct | Sell | 8212025 | 114.93 | 1,571 | 180,555 | 582,350 | Form | |
| 41 | Bickham, W Bradley | President and COO | Direct | Sell | 8152025 | 115.34 | 9,000 | 1,038,100 | 4,902,716 | Form |
| 42 | Lopez, Esteban | Direct | Sell | 8112025 | 109.00 | 522 | 56,898 | 437,744 | Form | |
| 43 | Stevenson, Roberton James | EVP & Chief HR Officer | Direct | Sell | 6172025 | 112.99 | 228 | 25,762 | 1,421,866 | Form |
| 44 | Tucker, David W | EVP / Chief Strategy Officer | Direct | Sell | 6122025 | 115.43 | 2,403 | 277,378 | 1,008,281 | Form |
Industry Resources
| Health Care Resources |
| U.S. National Library of Medicine |
| ClinicalTrials.gov |
| Modern Healthcare |
| Healthcare Dive |
| Fierce Healthcare |
| Health Affairs |
| Health Data Management |
| FDA Tracker |
| Health Care Services Resources |
| HealthLeaders Media |
| Medical Economics |
| Physicians Practice |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.